Related Experiment Video
Updated: Jan 15, 2026

Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue
Published on: July 28, 2023
Mesenchymal stem cells attenuate keloid pathogenesis via TGF-β1/SMAD-driven MMP9 suppression: mechanistic insights
Yujia Zhao1, Hexiao Zhang2,3, Qiuyan Han1
1Department of Plastic and Medical Aesthetic Surgery, The Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Hexi District, Tianjin 300211, China.
Abstract:
Keloids, characterized by excessive collagen deposition and recurrence, pose significant therapeutic challenges due to limited mechanistic understanding. Mesenchymal stem cells (MSCs) exhibit potential for keloid management, but their precise mechanisms remain unclear. This study investigated how MSCs modulate extracellular matrix (ECM) remodeling in keloid pathogenesis. Using a co-culture system of human umbilical cord MSCs (UC-MSCs) and immortalized keloid fibroblasts (HDIKFs), we demonstrated that UC-MSCs significantly suppressed HDIKF proliferation (via CCK8 assay) and migration (via wound healing assay). Interestingly, UC-MSCs did not alter keloid xenograft growth in vivo. Mechanistically, quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) revealed selective downregulation of matrix metalloproteinases 9 (MMP9) in HDIKFs co-cultured with UC-MSCs, while MMP1, MMP2, and MMP3 remained unaffected. This suppression was linked to inhibition of the transforming growth factor-β1/SMAD (TGF-β1/SMAD) pathway, evidenced by reduced hypoxia-inducible factor-1α (HIF-1α) and SMAD2 expression, alongside upregulated interleukin-10 receptor alpha (IL-10RA). Additionally, UC-MSCs did not alter collagen I/III (COL I/III) ratios or phosphatidylinositol-3-kinase (PI3K)/protein kinase B (AKT) signaling. These findings highlight that MSCs attenuate keloid fibroblast activity through TGF-β1/SMAD-driven MMP9 suppression and IL-10RA enhancement, offering novel insights into MSC-based strategies for ECM homeostasis. This study underscores MMP9 as a therapeutic target and provides a foundation for refining MSC efficacy in keloid treatment.
Insights
Mesenchymal stem cells (MSCs) reduce keloid fibroblast activity by suppressing matrix metalloproteinases 9 (MMP9) via the transforming growth factor-β1/SMAD pathway. This study reveals MSCs
Area of Science:
- Cell biology
- Dermatology
- Regenerative Medicine
Background:
- Keloids present therapeutic challenges due to excessive collagen and recurrence.
- Mesenchymal stem cells (MSCs) show promise for keloid treatment, but mechanisms are unclear.
- Understanding MSCs' role in extracellular matrix (ECM) remodeling is crucial for keloid pathogenesis.
Purpose of the Study:
- To investigate how MSCs modulate ECM remodeling in keloid pathogenesis.
- To elucidate the specific molecular mechanisms by which MSCs affect keloid fibroblasts.
- To identify potential therapeutic targets for keloid treatment.
Main Methods:
- Co-culture of human umbilical cord MSCs (UC-MSCs) with immortalized keloid fibroblasts (HDIKFs).
- Assays used: CCK8 for proliferation, wound healing for migration, quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) for gene expression.
- Analysis of key signaling pathways: transforming growth factor-β1/SMAD (TGF-β1/SMAD), hypoxia-inducible factor-1α (HIF-1α), and interleukin-10 receptor alpha (IL-10RA).
Main Results:
- UC-MSCs significantly suppressed keloid fibroblast proliferation and migration in vitro.
- UC-MSCs selectively downregulated matrix metalloproteinases 9 (MMP9) expression in keloid fibroblasts.
- Suppression of MMP9 was linked to inhibition of the TGF-β1/SMAD pathway, reduced HIF-1α and SMAD2, and increased IL-10RA.
Conclusions:
- MSCs attenuate keloid fibroblast activity via TGF-β1/SMAD-driven MMP9 suppression and IL-10RA enhancement.
- MMP9 is identified as a key therapeutic target for keloid management.
- Findings provide a foundation for optimizing MSC-based therapies for ECM homeostasis in keloids.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Related Concept Videos
Mesenchymal Stem Cells
Role of Matrix Metalloproteases in Degradation of ECM
TGF - β Signaling Pathway
Extracellular Matrix
Clinical Applications of Epidermal Stem Cells
Tissue Renewal without Stem Cells
However, failure of such a system...